New system that defines Huntington's disease will 'revolutionize' drug trials

A novel staging framework that assesses the progression of Huntington's disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; this 'significant' step paves the way for clinical trials of drugs in the earliest phase of disease.

source https://medicalxpress.com/news/2022-06-huntington-disease-revolutionize-drug-trials.html